Data is not available at this time.
Universal Health Services, Inc. (UHS) is a diversified healthcare provider operating acute care hospitals and behavioral health facilities across the U.S., U.K., and Puerto Rico. The company generates revenue through two primary segments: Acute Care Hospital Services, offering surgical, diagnostic, and emergency care, and Behavioral Health Care Services, addressing mental health and addiction treatment. With 363 inpatient and 40 outpatient facilities, UHS holds a strong regional presence, leveraging economies of scale in purchasing and administrative efficiencies. The company competes in the fragmented healthcare services sector, differentiating itself through integrated care models and a dual focus on physical and behavioral health. Its scale allows for cost-effective operations, while its geographic diversification mitigates regional market risks. UHS also provides ancillary services like insurance and management support, enhancing its value proposition to patients and payers.
UHS reported FY2024 revenue of $15.8 billion, with net income of $1.14 billion, reflecting a 7.2% net margin. Operating cash flow stood at $2.07 billion, underscoring robust cash generation. Capital expenditures of $943.8 million indicate ongoing investments in facility upgrades and expansions. The company’s operational efficiency is evident in its ability to convert revenue into cash flow, supporting both growth and debt management.
Diluted EPS of $16.82 highlights UHS’s earnings strength, driven by its dual-segment model. The company’s capital efficiency is supported by its scalable infrastructure, which optimizes fixed costs across its extensive network. Operating cash flow coverage of capital expenditures (2.2x) demonstrates sustainable reinvestment capacity, while its asset-light management services segment contributes to higher-margin revenue streams.
UHS maintains a leveraged balance sheet with total debt of $4.96 billion against cash reserves of $126 million. The debt load is manageable given its stable cash flows, but interest coverage remains a focus. The company’s liquidity position is adequate, with operating cash flow sufficient to service obligations and fund growth initiatives without immediate refinancing needs.
UHS has consistently grown through organic expansions and acquisitions, particularly in behavioral health, a high-demand sector. The company pays a modest dividend ($0.80 per share), prioritizing reinvestment over shareholder returns. Growth trends are supported by demographic tailwinds, including aging populations and increasing mental health awareness, though regulatory pressures pose risks.
With a market cap of $12.1 billion and a beta of 1.3, UHS trades at a premium reflective of its defensive healthcare exposure and growth potential. Investors likely price in steady demand for its services, though reimbursement risks and labor costs could weigh on margins. The stock’s volatility aligns with broader market sensitivity.
UHS benefits from its diversified footprint, dual-segment resilience, and operational scale. Near-term challenges include labor shortages and regulatory scrutiny, but long-term demand for healthcare services remains robust. Strategic acquisitions and cost controls position the company to capitalize on industry consolidation and shifting care delivery models.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |